Darrin Disley

Disley, 49, played semi-professional football before discovering biotech. He joined gene-editing company Horizon Discovery 10 years ago: its genetically edited “patients in a test tube” help drug companies discover new medicines. Horizon completed rapid IP to IPO, acquiring US companies rather than more commonly the other way around, as well as delivering “personalised” cancer medicines rather than untargeted chemo and radiotherapies.

Request a Test Drive, a Quote or More Information


GET IN TOUCH